Active, not recruitingPhase 2NCT03395587
Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Studying Glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Principal Investigator
- Michael Sabel, Prof. MDDepartment of Neurosurgery
- Intervention
- Autologous, tumor lysate-loaded, mature dendritic cells (DC)(biological)
- Enrollment
- 136 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2027
Study locations (6)
- Klinik für Neurologie, Knappschaftskrankenhaus Bochum, Bochum, North Rhine-Westphalia, Germany
- Klinik für Neurochirurgie, Sana Kliniken Duisburg, Duisburg, North Rhine-Westphalia, Germany
- Neurochirurgische Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
- St. Marien Hospital Lünen, Klinik für Neurochirurgie, Lünen, North Rhine-Westphalia, Germany
- Klinik für Allgemeine Neurologie, Universitätsklinikum Münster, Münster, North Rhine-Westphalia, Germany
- Helios Klinikum Krefeld, Klinik für Neurochirurgie, Krefeld, Germany
Collaborators
German Federal Ministry of Education and Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03395587 on ClinicalTrials.govOther trials for Glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07501559A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)Jecho Biopharmaceuticals Co., Ltd.
- RECRUITINGPHASE2NCT07326566Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIBlack Diamond Therapeutics, Inc.
- RECRUITINGPHASE1NCT07464925A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaTetragon Biosciences Ltd
- RECRUITINGPHASE1, PHASE2NCT07346144Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade GliomaTrogenix ltd
- RECRUITINGNCT07411690Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial TumorsMedical University of Warsaw
- RECRUITINGPHASE1NCT07480941Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGPHASE2NCT07225621Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaAlpheus Medical, Inc.
- RECRUITINGPHASE1, PHASE2NCT073912155G-PEARL: Paxalisib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom